EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative performance of a commercial and in-house Mp1p antigen-detecting enzyme immunoassay for the rapid diagnosis of talaromycosis

Joseph Barwatt, Lottie Brown iD, Nguyen Thi Mai Thu, Paula Gonzalez, Sruthi Venugopalan, Heera Natesan Sambath, Ngo Thi Hoa, Jian-Piao Cai, Kwok-Yung Yuen, Jasper Fuk-Woo Chan, Vo Trieu Ly, Thuy Le

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0013248 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Joseph Barwatt und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Disease and International Health, Duke University School of Medicine, Durham, North Carolina, United States of America. Hauptthemen laut MEDLINE: Antigens, Fungal, Mycoses, Talaromyces. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Foundation for the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Several antigen-detection assays have been developed for the rapid diagnosis of talaromycosis , but their utility has been limited by a lack of commercial options. The aim of this study was to perform a head-to-head comparison of the performance of our in-house monoclonal antibody-based Mp1p antigen-detecting enzyme immunoassay (EIA) with its recently-developed commercial platform.

Methods

In this diagnostic accuracy, retrospective, case-cohort study, we compared the sensitivity, specificity, positive likelihood ratio (LR+) and negative likelihood ratio (LR-) of the commercial Wantai Mp1p EIA versus our in-house Mp1p EIA on paired plasma and urine samples from 424 hospitalized adults with advanced HIV disease, including 224 cases of proven talaromycosis, where Talaromyces marneffei was isolated in culture of blood or other clinical specimens, and 200 controls diagnosed with a range of other opportunistic infections. All participants were randomly selected from prospective cohorts recruited between 2011 and 2019 from five centers in Vietnam.

Results

The sensitivity of the Wantai and in-house Mp1p EIAs were comparable in plasma (95.1% vs 92.4%, P = 0.11), in urine (91.5% vs 87.1% P = 0.07), and in combined testing of plasma and urine (96.4% vs 96.0%, P = 1.00), where talaromycosis was diagnosed based on the positivity of either specimen. The specificity of the Wantai and in-house Mp1p EIAs were consistently high in plasma, in urine, and in combined testing (93 – 97%). The Wantai and in-house Mp1p EIAs provided substantially higher sensitivity than blood culture detection (96.4% and 96.0% vs 78.6%, P < 0.001). For both EIAs, LR+ were greater than 10 and LR- were less than 0.1, which increases the confidence to rule in or rule out talaromycosis.

Conclusions

The diagnostic performance of the Wantai Mp1p EIA was comparable to our validated in-house Mp1p EIA, and significantly more sensitive than blood culture, offering a standardized tool for the rapid diagnosis of talaromycosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, FungalMycosesTalaromycesHumansSensitivity and SpecificityRetrospective StudiesMaleFemaleAdultImmunoenzyme TechniquesMiddle AgedHIV InfectionsAntibodies, Monoclonal

Substanzen

Antigens, FungalAntibodies, Monoclonal

Autor:innen und Institutionen

  • Division of Infectious Disease and International Health, Duke University School of Medicine, Durham, North Carolina, United States of America.
  • Institute of Infection and Immunity, City St George's University, School of Health & Medical Sciences, London, United Kingdom.
  • St George's Hospital, St George's Hospital NHS Foundation Trust, London, United Kingdom.
  • Department of Internal Medicine, University of Nevada Reno School of Medicine, Reno, Nevada, United States of America.
  • Tropical Medicine Research Center for Talaromycosis, Parasitology and Microbiology Research Unit, Centre for Biomedical Research, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.
  • Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.

ORCID-Profile: Lottie Brown

Förderung

  • NIAID NIH HHS
  • Foundation for the National Institutes of Health

Zitieren

APA

Barwatt, J., Brown, L., Thu, N. T. M., Gonzalez, P., Venugopalan, S., Sambath, H. N., Hoa, N. T., Cai, J. P., Yuen, K. Y., Chan, J. F., Ly, V. T., & Le, T. (2025). Comparative performance of a commercial and in-house Mp1p antigen-detecting enzyme immunoassay for the rapid diagnosis of talaromycosis. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013248

Vancouver

Barwatt J, Brown L, Thu NTM, Gonzalez P, Venugopalan S, Sambath HN, et al. Comparative performance of a commercial and in-house Mp1p antigen-detecting enzyme immunoassay for the rapid diagnosis of talaromycosis. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013248

BibTeX
@article{Barwatt2025,
  author = {Barwatt, Joseph and Brown, Lottie and Thu, Nguyen Thi Mai and Gonzalez, Paula and Venugopalan, Sruthi and Sambath, Heera Natesan and Hoa, Ngo Thi and Cai, Jian-Piao and Yuen, Kwok-Yung and Chan, Jasper Fuk-Woo and Ly, Vo Trieu and Le, Thuy},
  title = {Comparative performance of a commercial and in-house Mp1p antigen-detecting enzyme immunoassay for the rapid diagnosis of talaromycosis},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0013248}
}
Kostenlos starten →